ANGELA MORRIS: Open Payments
NPI 1114698107 · CEDAR RAPIDS, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$418 in 23 payments from 6 companies in 2025. Trend: 2023 $431 · 2024 $258 · 2025 $418
Food & beverage: $418
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $150 |
| Vanda Pharmaceuticals Inc. | 4 | $108 |
| Otsuka America Pharmaceutical, Inc. | 4 | $72 |
| Axsome Therapeutics, Inc. | 2 | $41 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $25 |
| Collegium Pharmaceutical, Inc. | 1 | $21 |
Products named: VRAYLAR, FANAPT, REXULTI, Auvelity, CAPLYTA, Jornay PM.
Industry payments across IA — which companies pay providers there.
